title: Looking for the best target for biologic treatment of spondyloarthritis.
authors.affiliation: University Teaching Hospital (CHRU de Besançon) and Université de Franche-Comté, Boulevard Fleming, F-25030 Besançon, France dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D000818:Animals; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D058990:Molecular Targeted Therapy; D016032:Randomized Controlled Trials as Topic; D013167:Spondylitis, Ankylosing / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D000093242:Interleukin-6 Inhibitors
chemical_list: D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors